Barbara Roberts received her HIV diagnosis in 1996 when treatment options were limited and the prognosis felt grim. Three decades later, the 74-year-old continues thriving with the help of modern antiretroviral therapy and recently adopted an FDA-approved medication that simplifies her daily regimen.

Roberts represents a growing population of older adults living with HIV. Advances in treatment have transformed HIV from a terminal diagnosis into a manageable chronic condition. People diagnosed in the 1990s who adhered to treatment now live into their 70s and 80s with near-normal life expectancies.

The new medication Roberts uses represents the latest evolution in HIV care. Rather than managing multiple pills daily, newer formulations consolidate treatments into single-dose options or longer-acting injections. This reduces pill burden, improves adherence, and decreases the likelihood of missed doses that can lead to drug resistance.

Living with HIV for three decades requires consistent engagement with medical care. Roberts maintains regular appointments with her HIV specialist and monitors her viral load and CD4 counts. These markers determine treatment effectiveness and overall health status. Undetectable viral loads mean the virus cannot transmit sexually, a concept known as undetectable equals untransmittable, or U=U.

Managing HIV at older ages presents unique challenges. Aging with HIV increases risks for conditions like heart disease, bone loss, and cognitive changes. Healthcare providers must balance HIV treatment with managing these age-related concerns and potential drug interactions with other medications.

Roberts' story underscores how scientific progress extends both lifespan and quality of life for people with HIV. The stigma surrounding HIV diagnosis has also diminished as treatments improved and survival stories accumulated. Younger people diagnosed today can realistically plan careers, relationships, and retirements.

Current treatment guidelines emphasize starting therapy immediately after diagnosis and maintaining undetectable viral loads. For those living